Ensign Peak Advisors
CLX icon

Ensign Peak Advisors’s Clorox CLX Stock Holding History

Ensign Peak Advisors’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Buy
38,607
+3,668
+10% +$352K 0.01% 629
2026
Q1 		$3.62M Sell
34,939
-17,375
-33% -$1.97M 0.01% 594
2025
Q4 		$5.27M Sell
52,314
-86
-0.2% -$9.34K 0.01% 513
2025
Q3 		$6.46M Sell
52,400
-60,855
-54% -$7.55M 0.01% 549
2025
Q2 		$13.6M Buy
113,255
+28,372
+33% +$3.79M 0.02% 404
2025
Q1 		$12.5M Sell
84,883
-1,311
-2% -$200K 0.02% 403
2024
Q4 		$14M Buy
86,194
+13,745
+19% +$2.25M 0.02% 387
2024
Q3 		$11.8M Sell
72,449
-36,831
-34% -$5.46M 0.02% 427
2024
Q2 		$14.9M Buy
109,280
+826
+0.8% +$115K 0.03% 364
2024
Q1 		$16.6M Sell
108,454
-130,468
-55% -$19.5M 0.03% 356
2023
Q4 		$34.1M Sell
238,922
-21,540
-8% -$2.87M 0.07% 239
2023
Q3 		$34.1M Sell
260,462
-18,772
-7% -$2.85M 0.07% 207
2023
Q2 		$44.4M Buy
279,234
+59,840
+27% +$9.65M 0.09% 185
2023
Q1 		$34.7M Sell
219,394
-18,353
-8% -$2.75M 0.08% 215
2022
Q4 		$33.4M Sell
237,747
-2,939
-1% -$417K 0.08% 226
2022
Q3 		$30.9M Sell
240,686
-1,785
-0.7% -$258K 0.08% 214
2022
Q2 		$34.2M Sell
242,471
-451
-0.2% -$64.4K 0.08% 202
2022
Q1 		$33.8M Sell
242,922
-12,297
-5% -$1.88M 0.07% 215
2021
Q4 		$44.5M Sell
255,219
-61,364
-19% -$10.2M 0.09% 203
2021
Q3 		$52.4M Sell
316,583
-47
-0% -$8.09K 0.11% 169
2021
Q2 		$57M Sell
316,630
-15,108
-5% -$2.76M 0.11% 161
2021
Q1 		$64M Sell
331,738
-9,373
-3% -$1.8M 0.14% 148
2020
Q4 		$68.9M Buy
341,111
+2,553
+0.8% +$528K 0.16% 134
2020
Q3 		$71.2M Sell
338,558
-17,165
-5% -$3.82M 0.18% 108
2020
Q2 		$78M Sell
355,723
-25,066
-7% -$5.01M 0.21% 94
2020
Q1 		$66M Sell
380,789
-8,525
-2% -$1.41M 0.22% 90
2019
Q4 		$59.8M Buy
+389,314
New +$58.2M 0.16% 112

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ensign Peak Advisors's CLX Position: Q2 2026 in Review

Ensign Peak Advisors increased its Clorox (CLX) stake by 10% in Q2 2026, buying an estimated $352K and bringing the position to 38,607 shares worth $3.68M. The position accounts for 0.01% of the portfolio, ranked #629.

Ensign Peak Advisors first reported a position in CLX in Q4 2019 and has held it in 27 quarters since. The position peaked at $78M in Q2 2020. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Ensign Peak Advisors held 38,607 shares of Clorox worth $3.68M as of Q2 2026.
  • Ensign Peak Advisors bought 3,668 Clorox shares in Q2 2026, an estimated $352K.
  • Clorox made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #629 holding.
  • Ensign Peak Advisors first reported a position in Clorox in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Clorox position peaked at $78M in Q2 2020.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.